{"name":"PRD Therapeutics, Inc.","slug":"prd-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"PRD Therapeutics, Inc. is a biotechnology company focused on the development of innovative therapies. The company's lead candidate, PRD001, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYnphZTRxVzdqQ3AyZW1WeWZvRzE3MTVJbkI4QlNIcmo0YURKNVVYaEduWU9WVjZfX3pNNTZBcHl5M25ONktVb1VHY3NTS3h2cTMxQjU3STEzUnBVTWlITEt3Q1BBVzJ2T0d1TmVPUjZuVWZyVlJjUDBwMUJSanlhSi1ScnVXcmhQU21qUHRNODE0Zw?oc=5","date":"2026-03-31","type":"pipeline","source":"Morningstar","summary":"Empowering Investor Success - Morningstar","headline":"Empowering Investor Success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOUkp5SFdFNGV4Q0RrS1NuckhMQV9FU3Qyb20tR2lfazVDSEVkd0ZXWXlfYXJLTno2YnRKVl9SUDZrLU9EZTlCcmJxQngyWG9tbnVIdnItajNRM01jempTaVMzNERhS1NtOXdNajBTQ3gwUUxMRV9aSzRGWEhmaUU2NmJadjQ4VFdfNldYM0NLNnBOU3ZQbjFtRDNHaUF2ZFJqN0ZfeEhuMEpZTlVQMG9VTUxfTTRrcGNnMFpGZ1VCOHd5SVhzSlc5MzI1MDNFcTc1R0ZGZm1zVFBjMHpMczhTY0lmRm43VlpxX3IwT0tmSmtibFVMalE?oc=5","date":"2026-02-06","type":"regulatory","source":"PR Newswire","summary":"PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101 - PR Newswire","headline":"PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPekZjd1hkWHdFd0wzX21KNXpLWDB4SVZNVGExRVRfcG5wX0RiUnFzblVGSnh0Mm5xWHNqTUhTNHJta1NKUi1VdHpxYjVzS0lfa3lHVE9sc3RQS0JWdlNYRHl1QXBfWXozSHlwRlBaU3JRRksyXzZNLWlHQ21LVlNvRjFKZ0lpbVpVVUZhQW9YNGtrQndOUE5GemhkcjEyYVR0azhyWlpsakwxQ3BmZ3JXdXFHRWRUY3RZRGlkNGdCaVZFb0ZYUkliMg?oc=5","date":"2025-06-27","type":"trial","source":"Business Wire","summary":"PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001 - Business Wire","headline":"PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}